Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Homes | 19 | 2025 | 675 | 1.690 |
Why?
|
| Residence Characteristics | 6 | 2017 | 233 | 1.530 |
Why?
|
| Pediatric Obesity | 3 | 2016 | 126 | 1.160 |
Why?
|
| Environment | 3 | 2017 | 126 | 0.970 |
Why?
|
| Body Mass Index | 5 | 2017 | 888 | 0.880 |
Why?
|
| Stroke | 13 | 2023 | 1216 | 0.830 |
Why?
|
| Health Status | 3 | 2021 | 451 | 0.810 |
Why?
|
| Mexican Americans | 7 | 2015 | 14 | 0.670 |
Why?
|
| Food Supply | 2 | 2017 | 54 | 0.600 |
Why?
|
| United States | 28 | 2026 | 8126 | 0.560 |
Why?
|
| Male | 48 | 2026 | 31057 | 0.520 |
Why?
|
| Aged, 80 and over | 25 | 2026 | 5619 | 0.520 |
Why?
|
| Female | 49 | 2026 | 34105 | 0.500 |
Why?
|
| Statistics as Topic | 1 | 2017 | 148 | 0.500 |
Why?
|
| Aged | 34 | 2026 | 14955 | 0.490 |
Why?
|
| Fast Foods | 1 | 2016 | 13 | 0.480 |
Why?
|
| Models, Statistical | 3 | 2016 | 312 | 0.480 |
Why?
|
| Feeding and Eating Disorders | 3 | 2022 | 50 | 0.480 |
Why?
|
| Environment Design | 1 | 2016 | 22 | 0.470 |
Why?
|
| Medicare | 8 | 2025 | 617 | 0.470 |
Why?
|
| Frailty | 3 | 2022 | 129 | 0.450 |
Why?
|
| Humans | 63 | 2026 | 65502 | 0.450 |
Why?
|
| Atrial Fibrillation | 4 | 2025 | 873 | 0.440 |
Why?
|
| Brain Ischemia | 5 | 2017 | 424 | 0.420 |
Why?
|
| California | 7 | 2017 | 177 | 0.420 |
Why?
|
| Models, Theoretical | 1 | 2016 | 274 | 0.420 |
Why?
|
| Memantine | 2 | 2024 | 23 | 0.410 |
Why?
|
| Cross-Sectional Studies | 15 | 2026 | 2696 | 0.410 |
Why?
|
| Epidemics | 1 | 2013 | 25 | 0.400 |
Why?
|
| Anticoagulants | 4 | 2025 | 520 | 0.390 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 351 | 0.390 |
Why?
|
| Arthritis, Psoriatic | 2 | 2023 | 32 | 0.380 |
Why?
|
| Analgesics, Opioid | 4 | 2025 | 537 | 0.370 |
Why?
|
| Health Behavior | 1 | 2016 | 482 | 0.370 |
Why?
|
| Dementia | 3 | 2025 | 273 | 0.360 |
Why?
|
| Schools | 5 | 2017 | 170 | 0.350 |
Why?
|
| Spondylarthritis | 2 | 2023 | 39 | 0.350 |
Why?
|
| Antirheumatic Agents | 2 | 2024 | 225 | 0.340 |
Why?
|
| Child | 11 | 2024 | 4666 | 0.310 |
Why?
|
| Depression | 3 | 2025 | 917 | 0.310 |
Why?
|
| Schizophrenia | 2 | 2021 | 278 | 0.300 |
Why?
|
| Middle Aged | 24 | 2026 | 18271 | 0.300 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 170 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 344 | 0.300 |
Why?
|
| Physical Fitness | 3 | 2017 | 92 | 0.290 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 403 | 0.270 |
Why?
|
| Ambulatory Care | 3 | 2025 | 319 | 0.270 |
Why?
|
| Pain | 3 | 2025 | 403 | 0.270 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2024 | 50 | 0.260 |
Why?
|
| Sexism | 2 | 2024 | 33 | 0.250 |
Why?
|
| Sex Factors | 7 | 2024 | 997 | 0.250 |
Why?
|
| Homes for the Aged | 2 | 2025 | 161 | 0.250 |
Why?
|
| Delirium | 2 | 2025 | 55 | 0.250 |
Why?
|
| Central Nervous System Agents | 1 | 2026 | 11 | 0.240 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 127 | 0.240 |
Why?
|
| Polypharmacy | 1 | 2026 | 66 | 0.230 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 205 | 0.230 |
Why?
|
| Stroke Rehabilitation | 2 | 2017 | 50 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 38 | 0.230 |
Why?
|
| Adolescent | 9 | 2024 | 6361 | 0.230 |
Why?
|
| Nootropic Agents | 1 | 2025 | 13 | 0.230 |
Why?
|
| Atrial Flutter | 1 | 2025 | 33 | 0.230 |
Why?
|
| Multimorbidity | 1 | 2025 | 50 | 0.220 |
Why?
|
| Physical Education and Training | 2 | 2017 | 29 | 0.220 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 866 | 0.220 |
Why?
|
| Communication Barriers | 1 | 2025 | 70 | 0.220 |
Why?
|
| Regression Analysis | 5 | 2017 | 500 | 0.220 |
Why?
|
| Psychotropic Drugs | 1 | 2025 | 83 | 0.210 |
Why?
|
| Risk Factors | 11 | 2024 | 5440 | 0.210 |
Why?
|
| Insurance, Health | 2 | 2022 | 152 | 0.210 |
Why?
|
| Frail Elderly | 2 | 2022 | 114 | 0.200 |
Why?
|
| Retrospective Studies | 10 | 2025 | 6877 | 0.200 |
Why?
|
| Texas | 7 | 2017 | 60 | 0.200 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2023 | 10 | 0.200 |
Why?
|
| Restaurants | 2 | 2013 | 12 | 0.190 |
Why?
|
| Hospices | 1 | 2023 | 39 | 0.190 |
Why?
|
| Caregivers | 1 | 2026 | 293 | 0.190 |
Why?
|
| Hospice Care | 1 | 2023 | 73 | 0.190 |
Why?
|
| Bulimia | 1 | 2022 | 17 | 0.180 |
Why?
|
| Rheumatology | 1 | 2022 | 67 | 0.180 |
Why?
|
| Prescription Drug Misuse | 1 | 2022 | 21 | 0.180 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 292 | 0.180 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 304 | 0.170 |
Why?
|
| Geography, Medical | 1 | 2021 | 5 | 0.170 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 131 | 0.170 |
Why?
|
| Age Factors | 7 | 2022 | 1591 | 0.170 |
Why?
|
| Quality of Life | 2 | 2021 | 1271 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 493 | 0.170 |
Why?
|
| Gender Identity | 1 | 2021 | 70 | 0.160 |
Why?
|
| Prevalence | 5 | 2026 | 1440 | 0.160 |
Why?
|
| Young Adult | 7 | 2024 | 4815 | 0.160 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 151 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 366 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 715 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 167 | 0.160 |
Why?
|
| Adult | 12 | 2025 | 17399 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2024 | 2626 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 226 | 0.150 |
Why?
|
| Anticonvulsants | 1 | 2020 | 103 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 215 | 0.150 |
Why?
|
| Overweight | 2 | 2012 | 255 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 148 | 0.150 |
Why?
|
| Epilepsy | 1 | 2020 | 112 | 0.140 |
Why?
|
| Cluster Analysis | 2 | 2023 | 264 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2020 | 208 | 0.140 |
Why?
|
| Fibrinolytic Agents | 2 | 2017 | 175 | 0.140 |
Why?
|
| Mental Health Services | 1 | 2022 | 308 | 0.140 |
Why?
|
| Hypertension | 3 | 2021 | 613 | 0.140 |
Why?
|
| Minority Groups | 1 | 2019 | 143 | 0.130 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 749 | 0.130 |
Why?
|
| Comorbidity | 4 | 2025 | 1126 | 0.130 |
Why?
|
| Guideline Adherence | 3 | 2017 | 312 | 0.130 |
Why?
|
| Health Status Disparities | 2 | 2024 | 146 | 0.130 |
Why?
|
| Students | 1 | 2019 | 226 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 62 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 186 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2017 | 223 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 771 | 0.120 |
Why?
|
| Spatial Analysis | 1 | 2016 | 12 | 0.120 |
Why?
|
| Community Health Services | 1 | 2017 | 127 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 800 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2015 | 295 | 0.120 |
Why?
|
| Noninvasive Ventilation | 1 | 2016 | 69 | 0.120 |
Why?
|
| Bias | 1 | 2016 | 116 | 0.110 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 198 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 1391 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 408 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2022 | 822 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 924 | 0.110 |
Why?
|
| Social Support | 1 | 2017 | 388 | 0.110 |
Why?
|
| Population Surveillance | 4 | 2017 | 210 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 97 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 345 | 0.100 |
Why?
|
| Obesity | 2 | 2013 | 1269 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2024 | 376 | 0.100 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5818 | 0.090 |
Why?
|
| Patient Discharge | 3 | 2022 | 521 | 0.090 |
Why?
|
| Health Promotion | 1 | 2017 | 518 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2022 | 3344 | 0.090 |
Why?
|
| Telemedicine | 1 | 2017 | 360 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 259 | 0.090 |
Why?
|
| Diet | 1 | 2016 | 540 | 0.090 |
Why?
|
| Policy | 1 | 2012 | 56 | 0.090 |
Why?
|
| Physical Examination | 2 | 2022 | 110 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 511 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 486 | 0.080 |
Why?
|
| Geriatric Assessment | 2 | 2022 | 161 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 1574 | 0.080 |
Why?
|
| Self Report | 2 | 2025 | 391 | 0.080 |
Why?
|
| Legislation, Food | 1 | 2010 | 3 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2010 | 20 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2026 | 2778 | 0.080 |
Why?
|
| Beverages | 1 | 2010 | 68 | 0.080 |
Why?
|
| Food | 1 | 2010 | 76 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1284 | 0.080 |
Why?
|
| School Health Services | 1 | 2010 | 80 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2509 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 763 | 0.070 |
Why?
|
| Incidence | 3 | 2015 | 1409 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 502 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 2431 | 0.060 |
Why?
|
| SEER Program | 1 | 2025 | 75 | 0.060 |
Why?
|
| Warfarin | 1 | 2025 | 125 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2025 | 293 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2025 | 118 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2024 | 45 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 344 | 0.050 |
Why?
|
| Population Health | 1 | 2024 | 17 | 0.050 |
Why?
|
| Language | 1 | 2025 | 153 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2025 | 129 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 18 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2025 | 137 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 1012 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 880 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2023 | 107 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2026 | 757 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 134 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 101 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 280 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 88 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 279 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 39 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 171 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2024 | 303 | 0.050 |
Why?
|
| Chronic Pain | 1 | 2024 | 152 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 175 | 0.040 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 20 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2021 | 6 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 45 | 0.040 |
Why?
|
| Age of Onset | 1 | 2021 | 175 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2021 | 78 | 0.040 |
Why?
|
| Data Collection | 1 | 2022 | 382 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 878 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 406 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2021 | 179 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 223 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 161 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 392 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 145 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 198 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2020 | 36 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2021 | 193 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 172 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 741 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 305 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 250 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1474 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 766 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 20 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1698 | 0.030 |
Why?
|
| Michigan | 1 | 2017 | 44 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 904 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 1704 | 0.030 |
Why?
|
| Medicaid | 1 | 2021 | 379 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1049 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3785 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 555 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 114 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 184 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1279 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 126 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 531 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 582 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 57 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 526 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 748 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 139 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1113 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1124 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 32 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 1606 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 305 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2250 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 739 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2014 | 218 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 425 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 318 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 410 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 860 | 0.020 |
Why?
|
| Los Angeles | 1 | 2010 | 14 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2102 | 0.020 |
Why?
|
| State Government | 1 | 2010 | 33 | 0.020 |
Why?
|
| Commerce | 1 | 2010 | 59 | 0.020 |
Why?
|